SAN FRANCISCO, Oct. 10 – Incyte Genomics has enter a licensing and development alliance with molecular tools manufacturer Epoch Biosciences, the companies announced Wednesday.

The terms include Epoch’s licensing Palo Alto-based Incyte’s LifeSeq Gold and ZooSeq databases for development of oligonucleotide probes and Incyte naming Epoch the “preferred provider” of custom oligonucleotide probes in addition to receiving Epoch Eclipse Probe Systems for use in internal development.

Financial details of the agreement were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.